Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2017 Filed Dec 18, 2017 21:24 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
Tax withholdingCommon Stock | 2,879 | $51.75 | $148,988.25 |
DisclosureSEC source: 0001179110-17-015482 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,017 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:23 UTC |
LIPPS RANDALL ADirector · Chairman, President, and CEO
|
Tax withholdingCommon Stock | 4,400 | $51.75 | $227,700.00 |
DisclosureSEC source: 0001179110-17-015481 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,118 F3 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:23 UTC |
LIPPS RANDALL ADirector · Chairman, President, and CEO
|
Tax withholdingCommon Stock | 8,033 | $51.75 | $415,707.75 |
DisclosureSEC source: 0001179110-17-015481 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,518 F3 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:23 UTC |
Ngo Nhat HExec. VP, Strategy & Bus Dev.
|
Tax withholdingCommon Stock | 779 | $51.75 | $40,313.25 |
DisclosureSEC source: 0001179110-17-015480 · edgar.xml · nonDerivative · entry 3 Ngo Nhat H · CIK 0001305020 · Exec. VP, Strategy & Bus Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,579 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:23 UTC |
Ngo Nhat HExec. VP, Strategy & Bus Dev.
|
Tax withholdingCommon Stock | 1,628 | $51.75 | $84,249.00 |
DisclosureSEC source: 0001179110-17-015480 · edgar.xml · nonDerivative · entry 2 Ngo Nhat H · CIK 0001305020 · Exec. VP, Strategy & Bus Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,358 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 724 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-17-014344 · edgar.xml · derivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724 Underlying: Common Stock · 724 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-17-014344 · edgar.xml · derivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionCommon Stock | 724 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-014344 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
Kuipers Peter J.Executive V.P. CFO
|
SaleCommon Stock | 724 | $47.85 | $34,643.40 |
DisclosureSEC source: 0001179110-17-014344 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,820 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the exact price of $47.85. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-014344 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
Kuipers Peter J.Executive V.P. CFO
|
SaleCommon Stock | 4,000 | $47.72 | $190,893.20 |
DisclosureSEC source: 0001179110-17-014344 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,544 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $47.7233. The shares sold between $47.50 to $48.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
Exercise / conversionNq Stock Options (right to buy) · Derivative | 4,100 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001179110-17-014343 · edgar.xml · derivative · entry 6 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
Exercise / conversionNq Stock Options (right to buy) · Derivative | 4,100 | $0.00 Strike: $16.70 | $0.00 |
DisclosureSEC source: 0001179110-17-014343 · edgar.xml · derivative · entry 5 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2022-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
Exercise / conversionCommon Stock | 8,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-014343 · edgar.xml · nonDerivative · entry 4 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
SaleCommon Stock | 8,200 | $47.84 | $392,317.52 |
DisclosureSEC source: 0001179110-17-014343 · edgar.xml · nonDerivative · entry 3 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,008 F1 · price: The price reported in Column 4 is the average price of $47.7637. The shares sold between $47.40 to $48.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 23:01 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
SaleCommon Stock | 6,413 | $47.76 | $306,308.61 |
DisclosureSEC source: 0001179110-17-014343 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,208 F2 · price: F2 The price reported in Column 4 is the average price of $47.8436. The shares sold between $47.40 to $48.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:17 UTC |
DREW J CHRISTOPHERExe VP, Sales & Marketing
|
Exercise / conversionNon-qualified Options (right to buy) · Derivative | 22,500 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001179110-17-013819 · edgar.xml · derivative · entry 8 DREW J CHRISTOPHER · CIK 0001271482 · Exe VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2018-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:17 UTC |
DREW J CHRISTOPHERExe VP, Sales & Marketing
|
Exercise / conversionNon-qualified Options (right to buy) · Derivative | 7,250 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001179110-17-013819 · edgar.xml · derivative · entry 7 DREW J CHRISTOPHER · CIK 0001271482 · Exe VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 Underlying: Common Stock · 7,250 shares Expires 2019-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:17 UTC |
DREW J CHRISTOPHERExe VP, Sales & Marketing
|
Exercise / conversionCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013819 · edgar.xml · nonDerivative · entry 6 DREW J CHRISTOPHER · CIK 0001271482 · Exe VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:17 UTC |
DREW J CHRISTOPHERExe VP, Sales & Marketing
|
SaleCommon Stock | 22,500 | $47.71 | $1,073,544.75 |
DisclosureSEC source: 0001179110-17-013819 · edgar.xml · nonDerivative · entry 5 DREW J CHRISTOPHER · CIK 0001271482 · Exe VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,326 F3 · price: The price reported in Column 4 is the average price of $47.7131. The shares sold between $47.38 to $48.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:17 UTC |
DREW J CHRISTOPHERExe VP, Sales & Marketing
|
Exercise / conversionCommon Stock | 7,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013819 · edgar.xml · nonDerivative · entry 4 DREW J CHRISTOPHER · CIK 0001271482 · Exe VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:17 UTC |
DREW J CHRISTOPHERExe VP, Sales & Marketing
|
SaleCommon Stock | 7,250 | $47.94 | $347,570.08 |
DisclosureSEC source: 0001179110-17-013819 · edgar.xml · nonDerivative · entry 3 DREW J CHRISTOPHER · CIK 0001271482 · Exe VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,576 F1 · price: The price reported in Column 4 is the average price of $47.9407. The shares sold between $47.55 to $48.50. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 06, 2017 Filed Nov 6, 2017 22:41 UTC |
Taborga Jorge R.Executive VP. Engineering
|
SaleCommon Stock | 6,295 | $48.69 | $306,484.67 |
DisclosureSEC source: 0001179110-17-013786 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,718 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $48.6870. The shares sold between $48.35 to $48.95. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2017 Filed Oct 2, 2017 23:02 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 362 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-17-012860 · edgar.xml · derivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362 Underlying: Common Stock · 362 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| October 02, 2017 Filed Oct 2, 2017 23:02 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-17-012860 · edgar.xml · derivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| October 02, 2017 Filed Oct 2, 2017 23:02 UTC |
Kuipers Peter J.Executive V.P. CFO
|
SaleCommon Stock | 170 | $50.90 | $8,653.00 |
DisclosureSEC source: 0001179110-17-012860 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,544 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the exact price of $50.90. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2017 Filed Oct 2, 2017 23:02 UTC |
Kuipers Peter J.Executive V.P. CFO
|
SaleCommon Stock | 362 | $50.90 | $18,425.80 |
DisclosureSEC source: 0001179110-17-012860 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,714 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the exact price of $50.90. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2017 Filed Oct 2, 2017 23:02 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionCommon Stock | 3,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-012860 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| October 02, 2017 Filed Oct 2, 2017 23:02 UTC |
Kuipers Peter J.Executive V.P. CFO
|
SaleCommon Stock | 3,000 | $50.97 | $152,919.00 |
DisclosureSEC source: 0001179110-17-012860 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,714 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $50.9730. The shares sold between $50.80 to $51.15. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:56 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
Exercise / conversionNon qualified option (right to buy) · Derivative | 9,870 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-17-012344 · edgar.xml · derivative · entry 4 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,780 Underlying: Common Stock · 9,780 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · derivative.underlying_shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:56 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
Exercise / conversionCommon Stock | 9,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-012344 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:56 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
SaleCommon Stock | 9,780 | $48.97 | $478,965.72 |
DisclosureSEC source: 0001179110-17-012344 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,116 F1 · shares: The price reported in Column 4 is the average price of $48.9740. The shares sold between $48.05 to $49.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 05, 2017 Filed Sep 5, 2017 22:53 UTC |
PETERSMEYER GARY SDirector
|
SaleCommon Stock | 1,000 | $51.73 | $51,734.00 |
DisclosureSEC source: 0001179110-17-012025 · edgar.xml · nonDerivative · entry 2 PETERSMEYER GARY S · CIK 0001206986 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,260 F1 · price: The price reported in Column 4 is the average price of $51.7340. The shares sold between $51.7250 to $51.7550. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:31 UTC |
LIPPS RANDALL ADirector · Chairman, President, and CEO
|
Exercise / conversionNon-Qualified Options (right to buy) · Derivative | 10,625 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-17-011961 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 Underlying: Common Stock · 10,625 shares Expires 2024-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:31 UTC |
LIPPS RANDALL ADirector · Chairman, President, and CEO
|
SaleCommon Stock | 10,625 | $52.00 | $552,537.19 |
DisclosureSEC source: 0001179110-17-011961 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,551 F4 · price: The price reported in Column 4 is the average price and the shares sold between $52.00 to $52.0050. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:31 UTC |
LIPPS RANDALL ADirector · Chairman, President, and CEO
|
Exercise / conversionCommon Stock | 10,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011961 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 18, 2017 Filed Aug 18, 2017 21:53 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
Exercise / conversionNq Stock Options (right to buy) · Derivative | 4,200 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001179110-17-011676 · edgar.xml · derivative · entry 6 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200 Underlying: Common Stock · 4,200 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2017 Filed Aug 18, 2017 21:53 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
Exercise / conversionNq Stock Options (right to buy) · Derivative | 4,200 | $0.00 Strike: $16.70 | $0.00 |
DisclosureSEC source: 0001179110-17-011676 · edgar.xml · derivative · entry 5 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200 Underlying: Common Stock · 4,200 shares Expires 2022-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan Read SEC document |
| August 18, 2017 Filed Aug 18, 2017 21:53 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
Exercise / conversionCommon Stock | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011676 · edgar.xml · nonDerivative · entry 4 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan Read SEC document |
| August 18, 2017 Filed Aug 18, 2017 21:53 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
SaleCommon Stock | 8,400 | $48.88 | $410,601.24 |
DisclosureSEC source: 0001179110-17-011676 · edgar.xml · nonDerivative · entry 3 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,221 F1 · price: The price reported in Column 4 is the average price of $48.8811. The shares sold between $48.30 to $49.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2017 Filed Aug 18, 2017 21:53 UTC |
JOHNSTON DAN SEVP-Chief Legal & Admin Off
|
SaleCommon Stock | 8,000 | $48.84 | $390,689.60 |
DisclosureSEC source: 0001179110-17-011676 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP-Chief Legal & Admin Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,621 F2 · price: F2 The price reported in Column 4 is the average price of $48.8362. The shares sold between $48.25 to $49.20. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
Exercise / conversionNon qualified Option (right to buy) · Derivative | 4,011 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · derivative · entry 6 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,011 Underlying: Common Stock · 4,011 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
Exercise / conversionNon qualified option (right to buy) · Derivative | 8,850 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · derivative · entry 5 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,850 Underlying: Common Stock · 8,850 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
Exercise / conversionCommon Stock | 12,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · nonDerivative · entry 4 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
SaleCommon Stock | 12,861 | $50.86 | $654,061.59 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,035 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $50.85620. The shares sold between $50.50 to $51.30. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC |
Seim Robin GeneEVP, Global A & M Adherence
|
SaleCommon Stock | 2,248 | $50.90 | $114,421.40 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,896 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $50.8992. The shares sold between $50.45 to $51.30. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2017 Filed Aug 9, 2017 23:43 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 6,532 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-17-011311 · edgar.xml · derivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,532 Underlying: Common Stock · 6,532 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2017 Filed Aug 9, 2017 23:43 UTC |
Kuipers Peter J.Executive V.P. CFO
|
Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-17-011311 · edgar.xml · derivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2025-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2017 Filed Aug 9, 2017 23:43 UTC |
Kuipers Peter J.Executive V.P. CFO
|
SaleCommon Stock | 6,532 | $50.29 | $328,500.81 |
DisclosureSEC source: 0001179110-17-011311 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,714 F2 · price: The price reported in Column 4 is the average price of $50.2910. The shares sold between $50.10 to $50.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2017 Filed Aug 9, 2017 23:43 UTC |
Kuipers Peter J.Executive V.P. CFO
|
SaleCommon Stock | 8,000 | $50.24 | $401,890.40 |
DisclosureSEC source: 0001179110-17-011311 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,246 F3 · price: The price reported in Column 4 is the average price of $50.2363. The shares sold between $50.10 to $50.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.